Rankings
▼
Calendar
RVMD (Revolution Medicines, Inc.) Stock Financials & Earnings | Market Cap Arena
RVMD
Revolution Medicines, Inc.
Mkt Cap
$20B
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$0
Net Income (TTM)
-$1.1B
EPS (TTM)
-$5.95
Free Cash Flow (TTM)
-$914M
Gross Margin
—
Op. Margin
—
Net Margin
—
FCF Margin
—
P/S Ratio (TTM)
—
P/E Ratio (TTM)
—
YoY Rev Growth
—
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$7M
$7M
-$75M
Q2 23
$4M
$4M
-$109M
Q3 23
$0
$0
-$123M
Q4 23
$742K
$742K
-$180M
Q1 24
$0
$0
-$141M
Q2 24
$0
$0
-$157M
Q3 24
$0
$0
-$176M
Q4 24
$0
$0
-$216M
Q1 25
$0
$0
-$241M
Q2 25
$0
$0
-$265M
Q3 25
$0
$0
-$315M
Q4 25
$0
-$5M
-$362M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
571.1x
—
Q2 23
673.5x
—
Q3 23
759.8x
—
Q4 23
1717.1x
—
Q1 24
4354.7x
—
Q2 24
26797.4x
—
Q3 24
26797.4x
—
Q4 24
—
—
Q1 25
—
—
Q2 25
—
—
Q3 25
—
—
Q4 25
—
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$62M
-$64M
Q2 23
-$67M
-$68M
Q3 23
-$100M
-$103M
Q4 23
-$121M
-$123M
Q1 24
-$161M
-$164M
Q2 24
-$128M
-$131M
Q3 24
-$130M
-$134M
Q4 24
-$138M
-$140M
Q1 25
-$194M
-$198M
Q2 25
-$222M
-$229M
Q3 25
-$207M
-$211M
Q4 25
-$274M
-$276M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$2M
Q2 23
$1M
Q3 23
$3M
Q4 23
$2M
Q1 24
$3M
Q2 24
$2M
Q3 24
$4M
Q4 24
$1M
Q1 25
$3M
Q2 25
$7M
Q3 25
$3M
Q4 25
$2M
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
-7.4%
+25.4%
Q2 23
-58.1%
+58.2%
Q3 23
-100.0%
+54.3%
Q4 23
-95.2%
+134.6%
Q1 24
-100.0%
+71.4%
Q2 24
-100.0%
+39.1%
Q3 24
—
+42.6%
Q4 24
-100.0%
+19.7%
Q1 25
—
+70.9%
Q2 25
—
+69.0%
Q3 25
—
+79.4%
Q4 25
—
+67.2%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$10M
138.3%
Q2 23
$13M
339.4%
Q3 23
$14M
—
Q4 23
$25M
3426.8%
Q1 24
$16M
—
Q2 24
$20M
—
Q3 24
$21M
—
Q4 24
$22M
—
Q1 25
$25M
—
Q2 25
$29M
—
Q3 25
$31M
—
Q4 25
$34M
—
marketcaparena.com
OpEx Breakdown
R&D
G&A
Quarter
R&D
G&A
Q1 23
$69M
$13M
Q2 23
$98M
$15M
Q3 23
$108M
$16M
Q4 23
$148M
$32M
Q1 24
$118M
$23M
Q2 24
$135M
$22M
Q3 24
$152M
$24M
Q4 24
$188M
$28M
Q1 25
$206M
$35M
Q2 25
$224M
$41M
Q3 25
$263M
$53M
Q4 25
$293M
$64M
marketcaparena.com
Revenue Segments
Collaboration Revenue Member
Quarter
Collaboration Revenue Member
Q1 23
$7M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$427M
$483M
$910M
Q2 23
$380M
$529M
$909M
Q3 23
$358M
$455M
$813M
Q4 23
$696M
$1.2B
$1.9B
Q1 24
$288M
$1.4B
$1.7B
Q2 24
$276M
$1.3B
$1.6B
Q3 24
$201M
$1.3B
$1.5B
Q4 24
$543M
$1.7B
$2.3B
Q1 25
$334M
$1.8B
$2.1B
Q2 25
$402M
$1.7B
$2.1B
Q3 25
$217M
$1.7B
$1.9B
Q4 25
$384M
$1.6B
$2.0B
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
95M
+6.4%
Q2 23
107M
+12.7%
Q3 23
109M
+2.2%
Q4 23
141M
+29.3%
Q1 24
165M
+16.7%
Q2 24
165M
+0.3%
Q3 24
167M
+1.0%
Q4 24
168M
+0.5%
Q1 25
188M
+12.2%
Q2 25
188M
-0.0%
Q3 25
189M
+0.6%
Q4 25
190M
+0.5%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 17
—
—
FY 18
—
—
FY 19
$527K
95
FY 20
$344K
125
FY 21
$156K
188
FY 22
$144K
246
FY 23
$31K
378
FY 24
$0
534
FY 25
$0
200K
marketcaparena.com